(1) CENTER.—The term ‘‘Center’’ means the 
Infectious Disease Monitoring Center established 
pursuant to section 3. 
(2) 
RELEVANT
CONGRESSIONAL
COMMIT-
TEES.—The term ‘‘relevant congressional commit-
tees’’ means— 
(A) the Committee on Foreign Relations of 
the Senate; 
(B) the Committee on Health, Education, 
Labor, and Pensions of the Senate; 
(C) the Committee on Foreign Affairs of 
the House of Representatives; and 
(D) the Committee on Energy and Com-
merce of the House of Representatives. 
(3) SECRETARY.—The term ‘‘Secretary’’ means 
the Secretary of State. 
SEC. 3. INFECTIOUS DISEASE MONITORING CENTER. 
(a) ESTABLISHMENT.—The Secretary, in consulta-
tion with the Secretary of Health and Human Services 
and the heads of other relevant Federal departments and 
agencies, shall— 
(1) establish an Infectious Disease Monitoring 
Center within the American Institute in Taiwan in 
Taipei, Taiwan; and 
VerDate Sep 11 2014 
16:16 Nov 09, 2021
Jkt 029200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H5870.IH
H5870
pamtmann on DSKBC07HB2PROD with BILLS
(2) not later than 1 year after the date of the 
enactment of this Act, complete a study of how best 
to establish the Center that includes— 
(A) consultation with the Taiwan Eco-
nomic and Cultural Representative Office in the 
United States, the Taiwan Centers for Disease 
Control, and any other relevant instrumental-
ities of the Taiwanese Government; and 
(B) a consideration of the personnel, mate-
rial, and funding requirements necessary to es-
tablish and operate the Center. 
(b) PARTNERSHIP.—The Center shall seek to partner 
with the Taiwan Centers for Disease Control to conduct 
health monitoring of infectious diseases in the region by— 
(1) regularly monitoring, analyzing, and dis-
seminating open-source material from countries in 
the 
region, 
including 
viral 
strains, 
bacterial 
subtypes, and other pathogens; 
(2) engaging in people-to-people contacts with 
medical specialists and public health officials in the 
region; 
(3) providing expertise and information on in-
fectious diseases to the Government of the United 
States and the Taiwanese Government; and 
VerDate Sep 11 2014 
16:16 Nov 09, 2021
Jkt 029200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H5870.IH
H5870
pamtmann on DSKBC07HB2PROD with BILLS
(4) carrying out other appropriate activities, as 
determined by the Director of the Center. 
(c) STAFFING.— 
(1) INFECTIOUS DISEASE EXPERTS.—The Sec-
retary of Health and Human Services shall annually 
submit a list to the Secretary that identifies not 
fewer than 3 infectious disease experts, from among 
the National Institutes of Health, the Centers for 
Disease Control and Prevention, and the Food and 
Drug Administration, who are recommended to serve 
as detailees to the Center. 
(2) OTHER PUBLIC HEALTH PROFESSIONALS.— 
The heads of other relevant Federal departments 
and agencies may submit recommendations to the 
Secretary of qualified persons within their respective 
departments and agencies to serve as detailees to the 
Center. 
(3) SELECTION.—The Secretary, after consid-
ering the detailees recommended pursuant to para-
graphs (1) and (2)— 
(A) shall appoint, for a period to be deter-
mined by the Secretary— 
(i) not fewer than 3 infectious disease 
experts detailed from among the National 
Institutes of Health, the Centers for Dis-
VerDate Sep 11 2014 
16:16 Nov 09, 2021
Jkt 029200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H5870.IH
H5870
pamtmann on DSKBC07HB2PROD with BILLS
ease Control and Prevention, and the Food 
and Drug Administration to work at the 
Center, including 1 expert to serve as the 
Director of the Center; and 
(ii) not fewer than 1 qualified person 
from any other relevant Federal depart-
ment or agency, including the Department 
of State and the United States Agency for 
International Development, to work at the 
Center; 
(B) may employ qualified foreign service 
nationals or locally engaged staff who are con-
sidered citizens of Taiwan to work at the Cen-
ter; and 
(C) may enter into agreements with the 
Taiwanese Government regarding employees of 
the Taiwan Centers for Disease Control who 
may be tasked with supporting or coordinating 
with the Center. 
(4) COMPENSATION.—Individuals appointed by 
the Secretary pursuant to clause (i) or (ii) of para-
graph (3)(A)— 
(A) shall be placed on leave without pay 
from their respective Federal departments and 
VerDate Sep 11 2014 
16:16 Nov 09, 2021
Jkt 029200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H5870.IH
H5870
pamtmann on DSKBC07HB2PROD with BILLS
agencies for the duration of such appointment; 
and 
(B) shall be compensated by the Depart-
ment of State. 
SEC. 4. REPORT. 
Not later than 1 year after the date of the enactment 
of this Act, the Secretary shall submit a report to the rel-
evant congressional committees that contains the results 
of the study described in section 3(a)(2), including— 
(1) a plan on how to establish and operate the 
Center, including— 
(A) the personnel, material, and funding 
requirements necessary to establish and operate 
the Center; and 
(B) the proposed structure and composi-
tion of Center personnel; 
(2) a description of the efforts that have been 
undertaken to establish the Center; and 
(3) a description of any consultations or agree-
ments between the Department of State and the 
Taiwanese Government regarding the establishment 
and operation of the Center, including— 
(A) the role that employees of the Taiwan 
Centers for Disease Control would play in sup-
porting or coordinating with the Center; and 
VerDate Sep 11 2014 
16:16 Nov 09, 2021
Jkt 029200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H5870.IH
H5870
pamtmann on DSKBC07HB2PROD with BILLS
(B) whether any employees of the Taiwan 
Centers for Disease Control would be detailed 
to, or co-located with, the Center. 
SEC. 5. AUTHORIZATION OF APPROPRIATIONS. 
(a) DEPARTMENT OF STATE.—There are authorized 
to be appropriated to the Department of State— 
(1) for fiscal year 2022, $300,000, of which— 
(A) $250,000 shall be used to conduct the 
study described in section 3(a)(2); and 
(B) $50,000 shall be used to determine the 
selection of detailees to the Center from among 
the National Institutes of Health, the Centers 
for Disease Control and Prevention, the Food 
and Drug Administration, and other relevant 
Federal departments or agencies; and 
(2) for fiscal year 2023, and each succeeding 
fiscal year, $50,000, which shall be used to deter-
mine the selection of detailees to the Center from 
among the National Institutes of Health, the Cen-
ters for Disease Control and Prevention, the Food 
and Drug Administration, and other relevant Fed-
eral departments or agencies. 
(b) AMERICAN INSTITUTE IN TAIWAN.—There are 
authorized to be appropriated to the American Institute 
VerDate Sep 11 2014 
16:16 Nov 09, 2021
Jkt 029200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H5870.IH
H5870
pamtmann on DSKBC07HB2PROD with BILLS
in Taiwan for fiscal year 2022, and each succeeding fiscal 
year, $1,300,000, of which— 
(1) $1,200,000 shall be used to employ the per-
sonnel described in section 3(c)(3); and 
(2) $100,000 shall be used for management ex-
penses related to operating the Center. 
Æ 
VerDate Sep 11 2014 
16:16 Nov 09, 2021
Jkt 029200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6301
E:\BILLS\H5870.IH
H5870
pamtmann on DSKBC07HB2PROD with BILLS